Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Statement re Possible Offer

6 Apr 2009 10:04

RNS Number : 1834Q
CareCapital Group plc
06 April 2009
 



CareCapital Group Plc

("CareCapital" or "the Company")

Statement re Possible Offer

The Board of CareCapital Group plc has noted the recent untoward share price movement and confirms that the Company's executive management team have indicated an interest in taking the Company private, which may or may not lead to an offer for the entire issued share capital of the Company. It is emphasised that discussions are at a very early stage.

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, the Company confirms that it has 76,754,096 Ordinary Shares of 1p each in issue and is admitted to trading on the London Stock Exchange under UK ISIN code GB00B16JQ761.

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of the Company, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of the Company, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of the Company by the Company, or by any of its respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

For further information, please contact:

Keith Gibbs, Non-executive director

c/o CareCapital Group Plc Tel: 020 7034 1949

Lindsay Mair/Charlotte Stranner

Daniel Stewart & Company plc Tel: 020 7776 6550

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDGCGDSXGGGGCL
Date   Source Headline
11th Oct 201611:37 amRNSHolding(s) in Company
11th Oct 201610:54 amRNSHolding(s) in Company
10th Oct 201611:44 amRNSDirectorate Change
30th Sep 20167:45 amRNSSubscription and Proposed Open Offer
30th Sep 20167:00 amRNSHalf-year Report
6th Sep 20167:00 amRNSAppointment of Director of Medical Physics
4th Aug 20165:05 pmRNSHolding(s) in Company
4th Aug 20168:13 amRNSHolding(s) in Company
27th Jul 20167:00 amRNSExercise of warrants
19th Jul 201611:27 amRNSHolding(s) in Company
19th Jul 201611:24 amRNSHolding(s) in Company
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
11th Jul 201610:06 amRNSDirector/PDMR Shareholding
8th Jul 20167:00 amRNSDirector/PDMR Shareholding
7th Jul 20166:01 pmRNSDirector/PDMR Shareholding
30th Jun 20164:19 pmRNSResult of AGM and share consolidation
22nd Jun 20167:00 amRNSAGM Presentation
7th Jun 20167:00 amRNSExercise of options and issue of shares
31st May 20167:00 amRNSFinal Results
26th May 20167:00 amRNS£24m financing secured for Harley Street
12th May 20164:02 pmRNSHolding(s) in Company
3rd May 20169:01 amRNSUpdate on Harley Street
18th Apr 20167:00 amRNSExercise of warrants and issue of shares
29th Mar 20167:00 amRNSUpdate on development milestones
1st Mar 20167:00 amRNSSenior Management Appointments
22nd Feb 20165:02 pmRNSHolding(s) in Company
8th Feb 20167:01 amRNSDirectorate Change
8th Feb 20167:00 amRNSThales industrialisation agreement
4th Feb 201612:35 pmRNSNomad change of name
21st Dec 20157:00 amRNSDirectors' Dealing
18th Dec 20152:42 pmRNSDirector Dealing
17th Dec 20159:40 amRNSDirector Dealing
24th Nov 20158:06 amRNSAppointment of Executive Chairman at ADAM
18th Nov 20157:00 amRNSDisposal of ORL
16th Nov 20157:00 amRNSSuccessful high power testing of CCL modules
21st Oct 20157:00 amRNSSecond commercial sale of proton therapy system
12th Oct 20157:00 amRNSOperator agreement with CircleHealth for Harley St
12th Oct 20157:00 amRNSStatement regarding new cancer centre
22nd Sep 20157:00 amRNSHalf Yearly Report
21st Sep 20153:31 pmRNSNotice of Results
21st Sep 20157:00 amRNSFirst milestone payment for China LIGHT system
3rd Sep 20159:34 amRNSChange of Registered Office & Trading address
24th Aug 20157:00 amRNSCCL modules ready for high-power testing
20th Aug 20157:00 amRNSSinophi agreement with Jilin University
10th Aug 201511:16 amRNSHolding(s) in Company
31st Jul 20157:00 amRNSExercise of warrants and options & issue of shares
29th Jul 20157:00 amRNSExercise of warrants and issue of shares
28th Jul 20157:00 amRNSDelivery of additional CCL unit & Harley St update
20th Jul 20153:10 pmRNSReplacement: Director Dealing and Award of Options
20th Jul 20157:00 amRNSDirector Dealing and Award of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.